Investor Alert for Shareholders of Gene Logic Inc.

0 Comments | M2 Presswire, April, 2007

M2 PRESSWIRE-27 April 2007-Biotech News: Investor Alert for Shareholders of Gene Logic Inc.(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:27042007 Gene Logic doesn't make drugs; it helps drugmakers make drugs. The company operates two business segments: information services, which offers bioinformatic tools (databases, data services); and drug repositioning services to help identify and restart potentially useful drugs that stalled during development.

Information services delivers over two-thirds of Gene Logic's revenues. Gene Logic's customers include drug companies as well as research and government institutions. The company also provides research and other support to the FDA's Center for Drug Evaluation and Research. Gene Logic has sold its preclinical division...